SEC Form 4 · accession 0000932440-15-000150
EAGLE PHARMACEUTICALS, INC. · EGRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owners
Jay Moorin
Director · 10% Owner
Alain Schreiber
Director · 10% Owner
ProQuest Management LLC
10% Owner
ProQuest Investments IV, L.P.
10% Owner
ProQuest Associates IV LLC
10% Owner
Period of report
May 6, 2015
Accepted (ET)
May 7, 2015 · 5:42 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000827871
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 par valueF2,F1 | May 6, 2015 | J | 9,903 | $0.00 | D | 62,031 | I | By ProQuest Management LLC Plans |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares are held in a ProQuest Management LLC Defined Benefit Pension Plan ("DBPP") FBO Jay Moorin and a ProQuest Management LLC Salary Savings Plan FBO Jay Moorin and for the benefit of certain other individuals. Jay Moorin and Alain Schreiber are trustees of ProQuest Management LLC DBPP FBO Jay Moorin and the ProQuest Management LLC Salary Savings Plan FBO Jay Moorin and for the benefit of certain other individuals. Each of the Reporting Persons disclaims beneficial ownership of such securities except to the extent of each Reporting Person's pecuniary interest in such securities.
- F2The Reporting Persons transferred the shares from ProQuest Management LLC Salary Savings Plan FBO Jay Moorin and for the benefit of certain other individuals to an employee's separate IRA, with no additional consideration paid by the employee.